This Article Free Full Text (Free OnlineFirst PDF) All Versions of this Article: 0192623308318216v1 36/4/632    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wolf, D. C. Articles by Lau, C. Search for Related Content PubMed PubMed Citation Articles by Wolf, D. C. Articles by Lau, C. Social Bookmarking                         What's this?

Comparative Hepatic Effects of Perfluorooctanoic Acid and WY 14,643 in PPAR- Knockout and Wild-type Mice

^* To whom correspondence should be addressed. E-mail: rosen.mitch{at}epa.gov.

	Abstract

Perfluorooctanoic acid (PFOA) is a chemical used in the production of fluoropolymers. Its persistence in the environment and presence in humans and wildlife has raised health concerns. Liver tumor induction by PFOA is thought to be mediated in rodents by PPAR-. A recent US EPA scientific advisory board questioned the contribution of PPAR-in PFOA-induced liver tumors. Liver response in CD-1, SV/129 wild-type (WT), and PPAR-knockout (KO) SV/129 mice was evaluated after seven daily treatments of PFOA-NH₄⁺ (1, 3, or 10 mg/kg, p.o.) or the prototype PPAR-agonist Wyeth 14,643 (WY, 50 mg/kg). Livers were examined by light and electron microscopy. Proliferation was quantified after PCNA immunostaining. PFOA treatment induced a dose-dependent increase in hepatocyte hypertrophy and labeling index (LI) similar to WY in WT mice. Ultrastructural alterations of peroxisome proliferation were similar between WY-treated and 10 mg/kg PFOA-treated WT mice. KO mice had a dose-dependent increase in hepatocyte vacuolation but increased LI only at 10 mg PFOA/kg. WY-treated KO mice were not different from KO control. These data suggest that PPAR-is required for WY- and PFOA-induced cellular alterations in WT mouse liver. Hepatic enlargement observed in KO mice may be due to an accumulation of cytoplasmic vacuoles that contain PFOA.

First published on May 8, 2008, doi:10.1177/0192623308318216

Toxicologic Pathology 2008;36:632.

A more recent version of this article appeared on June 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. A. Bjork and K. B. Wallace Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid-Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell Cultures Toxicol. Sci., September 1, 2009; 111(1): 89 - 99. [Abstract] [Full Text] [PDF]

				X. Cheng and C. D. Klaassen Critical Role of PPAR-{alpha} in Perfluorooctanoic Acid- and Perfluorodecanoic Acid-Induced Downregulation of Oatp Uptake Transporters in Mouse Livers Toxicol. Sci., November 1, 2008; 106(1): 37 - 45. [Abstract] [Full Text] [PDF]

				M. B. Rosen, B. D. Abbott, D. C. Wolf, J. C. Corton, C. R. Wood, J. E. Schmid, K. P. Das, R. D. Zehr, E. T. Blair, and C. Lau Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid Toxicol Pathol, June 1, 2008; 36(4): 592 - 607. [Abstract] [Full Text] [PDF]